Financials

  • Market Capitalization 80.76 M
  • Employee 6
  • Founded 1981
  • CEO Eric A. Adams
  • Website www.mentaritx.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000BT4589
  • Industry N/A
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
7046
LYR
30.1600 USD-2.77%-7.26%-7.85%-7.85%0 USD
7047
LYRI
14.1650 USD-3.70%-4.81%-7.36%-7.36%0 USD
7049
MFIX
24.8815 USD-0.13%-0.07%-0.67%-0.67%0 USD
7050
SMDC
19.1400 USD-3.09%-6.34%-7.36%-7.36%0 USD

Frequently asked questions about Mentari Therapeutics, Inc. Common Stock

What is the Mentari Therapeutics, Inc. Common Stock stock price today?

The current price of Mentari Therapeutics, Inc. Common Stock (MTRI) is 14.70. Over the past 24 hours, the stock has changed by -3.54%. Follow the MTRI chart for real-time price dynamics.

What is the stock ticker of Mentari Therapeutics, Inc. Common Stock?

Mentari Therapeutics, Inc. Common Stock trades under the ticker MTRI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Mentari Therapeutics, Inc. Common Stock stock going up?

MTRI has changed by -18.33% over the last week, -0.68% over the last month, and -0.68% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Mentari Therapeutics, Inc. Common Stock?

Mentari Therapeutics, Inc. Common Stock currently has a market capitalization of 80.76 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Mentari Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Mentari Therapeutics, Inc. Common Stock reported earnings of -4.2 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Mentari Therapeutics, Inc. Common Stock revenue for the last quarter?

Mentari Therapeutics, Inc. Common Stock reported quarterly revenue of 1 488. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Mentari Therapeutics, Inc. Common Stock net income for the last quarter?

Mentari Therapeutics, Inc. Common Stock reported net income of -2.33 M for the last quarter. The previous quarter showed -5.84 M, which means net income changed by +60.09%.

How many employees does Mentari Therapeutics, Inc. Common Stock have?

As of the latest available data, Mentari Therapeutics, Inc. Common Stock has 6 employees. Workforce size can provide additional context about the company's scale and operations.

What is Mentari Therapeutics, Inc. Common Stock EBITDA?

Mentari Therapeutics, Inc. Common Stock EBITDA is -2.01 M, and its EBITDA margin is -135.4 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Mentari Therapeutics, Inc. Common Stock stock?

You can buy Mentari Therapeutics, Inc. Common Stock (MTRI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Mentari Therapeutics, Inc. Common Stock stock?

Investing in Mentari Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MTRI chart and related analysis on metatrader.com as part of your research.